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Periorbital postinflammatory hyperpigmentation after
plasma exeresis
Dear Editor
Postinflammatory hyperpigmentation (PIH) developing after cos-
metic procedures, such as chemical peeling and laser therapies are
always a concern, has not been reported with plasma exeresis
(PlexR).
Plasma exeresis is considered to be a safe method suitable for all
skin types, because of the minimal dermal damage according to the
manufacturer and as shown in research.1-3 It is an effective non-
surgical treatment as an alternative for surgical upper and lower
blepharoplasty. Plasma is formed by this device through the ioniza-
tion of atmospheric gas. The amount of plasma generated depends
on which of the three Plexr devices is used. The white device has
0.7-W power and creates points on the skin with a diameter of
0.5 mm, the green device has 1-W power and creates 1 mm points,
and the red device is the strongest with 2-W power and 2 mm
points, respectively. This series of minuscule dots on the skin causes
an instant tightening and contraction of the skin fibers subsequently
leading to remodeling, lifting, and rejuvenating effects. After the
treatment, a crust on the treated part will form that falls off in about
a week, leaving no bruising or scarring.
Over the last 4 years (March 2016 through February 2020), we
have performed 164 nonsurgical upper and lower blepharoplasties
using plasma exeresis in 106 patients in our clinic. Sixty-four
patients had a single treatment, 31 patients had 2 treatments,
6 patients had 3 treatments, 1 patient had 4 treatments, and
4 patients had 5 treatments. The average time between the treat-
ments was 6 months. Recently, we have had two patients, a
37-year-old woman with Fitzpatrick skin type II (patient 1) and a
61-year-old woman with Fitzpatrick skin type IV (patient 2), who
experienced periorbital/periocular PIH after their first plasma
exeresis treatment using the red device. In both cases, the brown-
colored pigmentation occurred bilaterally after aesthetic plasma
exeresis treatment involving the lower periorbital region. It
appeared after the natural release of the crust in patient 1 after
6 days and patient 2, respectively, after 9 days. Both patients had
no history of allergy as in atopic or allergic contact dermatitis, nor
had other dermatological conditions (eg, lichen planus pigmentosus)
and did not use any drugs. They applied daily SPF 50 and had no
excessive exposure to the sun, nor used a tanning bed.
We have prescribed both patients hydroquinone 5% (HQ) in com-
bination with tretinoin 0.05% for bleaching of their hyperpigmented
skin after which a mild-to-moderate improvement was reached in
both patients. After 4 months, patient 1 was successfully treated with
a superficial herbal peel (Green Peel by Dr. Schrammek) and the pig-
mentation did not re-occur (Figure 1).
F IGURE 1 A, 1 day after treatment. B, 6 weeks after
treatment. C, 4 months after treatment
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Patient 2 was treated after 2 months with also the same superfi-
cial herbal peel with only minor improvement. Two weeks later, a gly-
colic acid peeling (Neostrata, 20% glycolic acid) was performed with
little further improvement. After this, patients 2 was treated four
times with thermomechanical ablation (Tixel on mode 10/500) which
resulted in the result as shown in Figure 2C after 9 months. Tixel is a
nonlaser fractional treatment technology that transfers thermal
energy to the skin through a matrix of tiny pyramid-shaped pins made
of biocompatible materials covering a treatment area of 1 cm2.
PIH can occur as a side effect of a plasma exeresis treatment in
any skin type. Our advice to practitioners is to have their patients
apply topical hydroquinone 5% cream each day for 4 weeks prior to
plasma exeresis treatment to prevent PIH. Since we have adopted this
new protocol, no new cases of PIH after plasma exeresis treatment
have occurred.
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F IGURE 2 A, Directly after treatment. B, 1 month after
treatment. C, 9 months after treatment
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